Expression of poly-ADP-ribose polymerase (PARP) in endometrial adenocarcinoma: Prognostic potential.

CONCLUSIONS: This study demonstrated the over-expression of the druggable target Parp-1 in endometrial adenocarcinoma and observed a strong negative correlation of native Parp-2 expression and disease progression via the quantification of the Parp proteins using enzyme- linked immuno-sorbent assay (ELISA) assays.
PMID: 32360251 [PubMed - as supplied by publisher]

Source: Pathology, Research and Practice - April 20, 2020 Category: Pathology Authors: Lawrence LM, Russell R, Denning CE, Zgheib NB, Salisbury T, Lirette ST, Valluri J, Claudio PP, Denning KL Tags: Pathol Res Pract Source Type: research